She currently serves on the WHO’s Malaria Policy Advisory Committee (MPAC) and Malaria Elimination Oversight Committee (MEOC).
Prof Ansah was the Vice Chair of the Global Fund’s Technical Review Panel (TRP) to combat HIV/AIDS, Tuberculosis and Malaria until 2019.
She is a Public Health Physician, an Epidemiologist, a fellow of the Ghana College of Physicians and Surgeons and a Rockefeller Foundation Bellagio Fellow. University of Health and Allied Sciences, GhanaĮvelyn Korkor Ansah is the Director of the Centre for Malaria Research.
She also leading a BRCCH-funded project to inform novel medical interventions against SARS-Cov-2 (find out more here). She is also a member of several WHO scientific or technical working groups and WHO Guideline Development Groups. Her group has also developed new models of SARS-CoV-2 dynamics and applied them to inform decisions on novel interventions against COVID-19. This work includes new approaches using mechanistic models to inform quantitative target product profiles for novel malaria tools. Her recent research focuses on developing data- and epidemiology-informed mathematical models and associated algorithms to understand pathogen, host, and intervention dynamics and to inform decisions during product development through implementation and policy recommendations. This evidence includes the likely public health impact and cost-effectiveness of new interventions, such as the world’s first malaria vaccine RTS,S/AS01 (20), and, more recently, novel immune therapies. She leads and has led international multi-institute consortia to provide evidence to WHO and other stakeholders for decision-making on new malaria interventions. She has more than 16 years of experience developing mathematical and computational models to provide quantitative evidence to support infectious disease control and elimination decisions, particularly for product development and policy decisions on new interventions. Melissa Penny is a professor and Head of the Disease Modelling research unit at Swiss TPH. Swiss Tropical and Public Health Institute & University of Basel, Switzerland There is a strong translational emphasis, with the most promising new approaches and/or candidate vaccines feeding into the Blood-Stage Malaria Clinical Trials Programme. In particular, the group’s research interests span: strategies for improved vaccine antigen identification development of improved vaccine delivery strategies assessment of quantitative antibody correlates of protective immunity, and assessment of human vaccine-induced antibody responses to guide structure-based immunogen design and to better understand protective mechanisms of immunity.Ī critical strength of the group is a strong dual focus on preclinical vaccine development in parallel with early-phase clinical vaccine testing and experimental medicine studies. The research undertaken in the Draper group focuses on the development of novel and improved approaches to blood-stage malaria vaccine design, as well as aiming to better understand molecular mechanisms of vaccine-induced immunity to blood-stage malaria infection. Simon Draper is a Professor of Vaccinology and Translational Medicine.
#Amadine medication registration#
In-person Registration (encouraged but not mandatory): HERE Where: Hybrid Zoom / Kollengienhaus, Hörsaal 116, PetersgraBasel Finally, Prof Evelyn Korkor Ansah (University of Health and Allied Sciences, Ghana) will provide insights into vaccine implementation and equitable distribution. Then, Prof Melissa Penny (Swiss TPH) will share her work on data analytics and modelling as product development support. Prof Simon Draper (University of Oxford, UK) will highlight the challenges, successes and future developments of vaccine-based solutions. Description: The BRCCH cordially invites you to join our seminar addressing the progress and prospects of malaria prevention.